My thesis aims to understand why prescribing trends for osteoporosis medication in England and France have started declining since about 2008. Indeed, after a very sharp increase since the late 1990s, the trends in prescription started stagnating and declining in England and France respectively since 2008.
As I review the literature – very slowly I must admit – I come to the conclusion that the epidemiology of the disease – i.e. the number of people actually afflicted by the condition – is very unlikely to bear any responsibility in the trends. Changes in epidemiology of this nature are simply not that fast. Though Western societies are ageing, the demography is similarly not changing that quickly.
I have prepared a number oh hypotheses as to why this is occurring. I will not list them now as this is not the objective of this paper. One of them is that osteoporosis may be declining within the ranking of public agenda priorities.